Phase II Study of GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients.

Trial Profile

Phase II Study of GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jul 2013

At a glance

  • Drugs Leuprorelin (Primary)
  • Indications Infertility
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Apr 2012 Planned end date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 13 Apr 2011 Planned End Date changed from 1 Nov 2011 to 1 Nov 2012, as reported by the ClinicalTrials.gov record
    • 28 Dec 2010 Planned end date changed from 1 Nov 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top